OMCS
SRPT icon

Old Mutual Customised Solutions’s Sarepta Therapeutics SRPT Stock Holding History

Old Mutual Customised Solutions’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-400
Closed -$15K – 1174
2013
Q2 		$15K Buy
+400
New +$14.3K ﹤0.01% 1435

Other funds holding SRPT

Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Old Mutual Customised Solutions's SRPT Position: Q3 2013 in Review

Old Mutual Customised Solutions sold out of Sarepta Therapeutics (SRPT) in Q3 2013, closing a stake of 400 shares — an estimated $15K sold.

Old Mutual Customised Solutions first reported a position in SRPT in Q2 2013 and held it in 1 quarter. The position peaked at $15K in Q2 2013. 134 funds tracked by Wall St. Rank hold SRPT as of Q3 2013.

  • Old Mutual Customised Solutions reported no remaining Sarepta Therapeutics position as of Q3 2013 after selling out during the quarter.
  • Old Mutual Customised Solutions sold 400 Sarepta Therapeutics shares in Q3 2013, an estimated $15K.
  • Old Mutual Customised Solutions first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 1 quarter.
  • Old Mutual Customised Solutions's Sarepta Therapeutics position peaked at $15K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2013.

Based on Old Mutual Customised Solutions's 13F filing for Q3 2013, filed 6 Nov 2013.